Holen Sie sich die Stockscreener-App
8.03
0.37%
0.03
Handel nachbörslich:
8.03
Schlusskurs vom Vortag:
$8.00
Offen:
$8
24-Stunden-Volumen:
256.86K
Relative Volume:
0.87
Marktkapitalisierung:
$537.82M
Einnahmen:
$555.06M
Nettoeinkommen (Verlust:
$-39.48M
KGV:
-13.38
EPS:
-0.6
Netto-Cashflow:
$29.05M
1W Leistung:
+11.37%
1M Leistung:
+11.68%
6M Leistung:
+9.70%
1J Leistung:
-16.18%
1-Tages-Spanne:
$7.6707
$8.18
1-Wochen-Bereich:
$7.20
$8.18
52-Wochen-Spanne:
$5.81
$11.25
Bioventus Inc Stock (BVS) Company Profile
Firmenname
Bioventus Inc
Sektor
Branche
Telefon
(919) 474-6700
Adresse
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Vergleichen Sie BVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
8.03 | 535.81M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Hochstufung | Craig Hallum | Hold → Buy |
| 2022-11-22 | Herabstufung | Craig Hallum | Buy → Hold |
| 2022-11-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Eingeleitet | Craig Hallum | Buy |
| 2021-11-15 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-11-10 | Fortgesetzt | JP Morgan | Overweight |
| 2021-07-01 | Herabstufung | Goldman | Buy → Neutral |
| 2021-03-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-08 | Eingeleitet | Goldman | Buy |
| 2021-03-08 | Eingeleitet | JP Morgan | Overweight |
| 2021-03-08 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioventus Inc Aktie (BVS) Neueste Nachrichten
Why Bioventus Inc. stock could rally in 20252025 Short Interest & Accurate Buy Signal Alerts - ulpravda.ru
Will Bioventus Inc. stock deliver consistent dividendsDay Trade & High Accuracy Trade Alerts - ulpravda.ru
Is Bioventus Inc. stock gaining market share2025 Earnings Impact & Breakout Confirmation Trade Signals - ulpravda.ru
Can Bioventus Inc. stock sustain revenue growthJuly 2025 Spike Watch & Community Consensus Stock Picks - ulpravda.ru
How risky is Bioventus Inc. stock nowJuly 2025 Setups & Free Daily Entry Point Trade Alerts - ulpravda.ru
Will Bioventus Inc. stock return to pre crisis levelsJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - ulpravda.ru
Why Bioventus Inc. stock could outperform in 2025Portfolio Value Summary & Low Risk High Win Rate Picks - ulpravda.ru
Hyaluronic Acid Products Market to Reach $20 billion, Globally, - openPR.com
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
(BVS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business - MSN
Will Bioventus Inc stock deliver consistent dividends2025 Earnings Impact & Growth Focused Investment Plans - moha.gov.vn
Bioventus (NYSE:BVS) Trading Down 1.1%Time to Sell? - MarketBeat
Why (BVS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Aug Analyst Calls: Why Bioventus Inc stock could outperform in 2025Gap Up & Weekly Breakout Opportunity Watchlist - moha.gov.vn
Why Bioventus Inc. stock is favored by top institutionsJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Улправда
What Wall Street predicts for Bioventus Inc. stock priceJuly 2025 Weekly Recap & Weekly Watchlist of Top Performers - Улправда
Will Bioventus Inc. stock benefit from automationJuly 2025 Institutional & Reliable Price Breakout Alerts - DonanımHaber
Will Bioventus Inc. stock rally after Fed decisionsJuly 2025 Opening Moves & Target Return Focused Stock Picks - Улправда
Is Bioventus Inc. stock resilient to inflation2025 Market WrapUp & Community Consensus Picks - Улправда
BVS (Bioventus) Purchase Of Investment : $0.0 Mil (TTM As of Sep. 2025) - GuruFocus
Bioventus (BVS) Receives a Buy from Canaccord Genuity - The Globe and Mail
Bioventus Earnings Notes - Trefis
(BVS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bioventus Reports Strong Q3 2025 Financial Performance - MSN
Bioventus (NYSE:BVS) Director Sells $75,700.00 in Stock - MarketBeat
Bioventus Director Guy P Nohra Sells 10,000 Shares - TradingView — Track All Markets
Dir Nohra Sells 10,000 ($75.7K) Of Bioventus Inc [BVS] - TradingView — Track All Markets
Divisadero Street Capital Management LP Decreases Stock Position in Bioventus Inc. $BVS - MarketBeat
Geode Capital Management LLC Has $6.98 Million Stake in Bioventus Inc. $BVS - Defense World
American Century Companies Inc. Grows Stock Holdings in Bioventus Inc. $BVS - Defense World
Buy Signal: Why Bioventus Inc stock is favored by top institutionsQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - moha.gov.vn
HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Bioventus Inc. (BVS) Presents at Piper Sandler 37th Annual Healthcare ConferenceSlideshow - Seeking Alpha
Dir Nohra Files To Sell 10,000 Of Bioventus Inc [BVS] - TradingView
Is It Too Late To Consider Buying Bioventus Inc. (NASDAQ:BVS)? - Yahoo Finance
Will Bioventus Inc. stock reach Wall Street targetsTrade Exit Summary & Real-Time Market Sentiment Reports - Newser
Will Bioventus Inc. stock see insider buyingWeekly Stock Report & Short-Term High Return Ideas - Newser
(BVS) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Bioventus: A New Start (NASDAQ:BVS) - Seeking Alpha
How Bioventus Inc. stock performs in weak economy2025 Top Gainers & Reliable Volume Spike Alerts - Newser
Bioventus (NASDAQ:BVS) Seems To Use Debt Quite Sensibly - 富途牛牛
Bioventus (NYSE:BVS) Trading Down 3.9%Here's What Happened - MarketBeat
Bioventus, Inc. Reports Strong Q3 Earnings Growth - MSN
Segall Bryant & Hamill LLC Purchases 232,302 Shares of Bioventus Inc. $BVS - MarketBeat
[Form 3] Bioventus Inc. Initial Statement of Beneficial Ownership - Stock Titan
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Bioventus (Nasdaq: BVS) to present at Piper Sandler 37th Healthcare Conference webcast - Stock Titan
Bioventus (NYSE:BVS) Shares Up 9.9%Time to Buy? - MarketBeat
Bioventus Appoints Ajay Dhankhar as New Director - MSN
Is Bioventus Inc. stock affected by interest rate hikesRisk Management & Weekly Chart Analysis and Guides - newser.com
Finanzdaten der Bioventus Inc-Aktie (BVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):